Testicular non-seminomatous germ cell carcinoma stage I, overall survival in patients following primary treatment

Testicular non-seminomatous germ cell carcinoma stage I, overall survival in patients following primary treatment

Juan F. Álvarez-Restrepo 1, Juan C. Álvarez-Restrepo 2, Juanita Laverde 3, Estefanía Celis-Reyes 4, David Ruiz-Londoño 4, Francisco L. Caro-Zapata 4, Rodolfo Varela-Ramírez 5

1 Departamento de Urología, Universidad de Antioquia, Medellín, Colombia; 2 Departamento de Urología, Universidad Nacional de Colombia, Bogotá, Colombia; 3 Facultad de Medicina, Universidad del Rosario, Bogotá, Colombia; 4 Departamento de Urología Oncológica, Instituto Nacional de Cancerología, Bogotá, Colombia; 5 Unidad de Urología, Departamento de Cirugía, Facultad de Medicina, Universidad Nacional de Colombia; 3Unidad de Urología Oncológica, Instituto Nacional de Cancerología; Bogotá, Colombia

*Correspondence: Juan F. Álvarez-Restrepo. Email: juanf.alvarez1@udea.edu.co

Abstract

Objective: To characterize overall survival (OS) and recurrence-free survival (RFS) in patients with stage I testicular non-seminomatous germ cell carcinoma (NSGCT) referred to different adjuvant treatment options.

Method: Patient search included inpiduals with stage I NSGCT who underwent radical orchiectomy from 2010 to 2022. The statistical description was conducted using measures of central tendency.

Results: In the regression model, no differences were observed.

Conclusions: No differences were found in OS or RFS. Prospective studies are needed to confirm these findings.

Keywords: Testicular neoplasm; Germ cell and embryonic neoplasms; Adjuvant chemotherapy

Contents

English version not available. Please check the Spanish version.

⇄ Versión en Español
DOI not available
Add to Mendeley

Text only available in Spanish.

    PERMANYER

    Mallorca, 310
    08037 Barcelona (España)

    Arquímedes, 190 – Colonia Polanco
    Delegación Miguel Hidalgo
    11560 Ciudad de México (México)

    RECURRING LINKS
    CLOCKSS is a dak archive that ensures the long-term survival of web-based scholary publications, governed by and for its stakeholders.

    This journal adheres to the principles established by the Committee on Publication Ethics

    English versión
    DOI not available

    Editorial times

    The editorial process consists of 6 stages:

    1. Reception of the manuscript (indeterminate, depending on whether the author meets the requirements): its objective is to verify that the manuscript complies with the specifications of these instructions for authors and that the submitted documentation is complete.

    2. Initial editorial review (maximum 5 business days): its objective is to corroborate the relevance, timeliness, originality, and scientific contribution of the manuscript, as well as the methodological and statistical soundness of the study. At this time, it will be submitted to an electronic plagiarism detection system. Derived from this, a rejected opinion may be obtained, or it will be sent for review by peer researchers.

    3. Review by peer researchers (maximum 30 business days): the opinion of at least two experts in the area in question will be obtained, who will evaluate the technical and methodological aspects of the investigation.

    4. Editorial review (maximum 7 business days): its objective is to make a decision based on the opinion of peer reviewers. The opinion can be rejected, major changes, minor changes or accepted. In the case of major or minor changes, it will be submitted again for evaluation by the initial peer reviewers.

    5. Final edition (6 weeks): its objective is the technical and linguistic edition (and translation), layout of galleys, DOI assignment, and correction by the author.

    6. Advanced publication: All manuscripts will be published ahead of print on the journal’s website as soon as they complete the editing process, until they are incorporated into a final issue of the journal.